Andrew McElroy

TRN - The Research Network Ltd

Drug discovery and development requires in-depth multi-disciplinary expertise which organisations may not always have in-house. The Research Network (TRN) enables direct access to a global network of highly experienced pharmaceutical professionals and service providers with a wide range of pre-clinical and clinical capability. Accessing expertise and scientific services via TRN is a flexible cost efficient route to progressing your projects with high quality data from pre-clinical to clinical stages of development. Within TRN you can work with one specific expert or the required network of expertise to move your project forward. TRN will help you to identify the most cost effective route to progress your project. TRN offers; Integrated project and strategic management (Target identification to Clinical PoC), grant writing and submission support, >60 experts globally and established relationships with a wide range of CROs. (Chemistry, biology, DMPK/ ADME, Drug Safety/ Toxicology, CMC Formulation, Regulatory & Clinical), Specific expertise in CVMD, Respiratory, Inflammation, Immunology, Virology, Dermatology, Pain, Oncology, CNS, Rare & Orphan Diseases, Small molecules and biologicals, TRN offers expertise gained in major pharma companies (Pfizer, AZ, Abbott, GSK, Millennium, Nycomed and others). TRN offers pay-as you-go drug discovery with a simple efficient contracting process, access to a quality CRO facilities, you retain all intellectual property. With its wide network and experience of many project and funding paradigms, TRN is well placed to find the right partners for your projects and to assist with securing funding. For any additional information about the services we provide or to contact us to discuss your requirements, please go to our website www.trn.net